Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.9168
-0.0832 (-8.32%)
At close: Dec 1, 2025, 4:00 PM EST
0.9249
+0.0081 (0.88%)
After-hours: Dec 1, 2025, 7:31 PM EST
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $44.5 million as of December 1, 2025. Its market cap has decreased by -51.29% in one year.
Market Cap
44.50M
Enterprise Value
16.09M
1-Year Change
-51.29%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $44.50M, a decrease of -89.90%. That is a compound annual growth rate of -39.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 44.50M | -32.53% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |